Estee Lauder’s expanded recovery plan could be the start of a new beginning for the cosmetics company, Wells Fargo analysts say in a research note. “Estee Lauder isn’t perfect, but with the potential for a sales inflection in the 2H, into margin recovery FY25/26, it may not be long before it sees prospects for upside to EPS,” say the analysts, which could bring the stock back above $200. But Wells Fargo warns, if Estee Lauder doesn’t see a recovery in Asia Travel Retail/China, and trends worsen outside of these geographies, earnings could stagnate. Wells Fargo raises its target price to $175 from $155 previously. Shares drop 2.9% to $145.97.